![Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC](https://journals.sagepub.com/cms/10.1177/1073274818789357/asset/images/large/10.1177_1073274818789357-fig1.jpeg)
Human Plasma Levels of Vascular Endothelial Growth Factor, Matrix Metalloproteinase 9, and Tissue Inhibitor of Matrix Metalloproteinase 1 and Their Applicability as Tumor Markers in Diagnoses of Cervical Cancer Based on ROC
![Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting](https://www.frontiersin.org/files/Articles/479117/fonc-09-00827-HTML/image_m/fonc-09-00827-t001.jpg)
Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
![Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/3e6d9fdf-2cd4-463f-bb34-e5c11fcfa603/fx1_lrg.jpg)
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers: Molecular Therapy - Oncolytics
![First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/12/4417/F1.large.jpg)
First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers | Anticancer Research
![Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-72055-x/MediaObjects/41598_2020_72055_Fig1_HTML.png)
Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis | Scientific Reports
![Proteomes | Free Full-Text | Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer Proteomes | Free Full-Text | Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer](https://www.mdpi.com/proteomes/proteomes-10-00013/article_deploy/html/images/proteomes-10-00013-g001.png)
Proteomes | Free Full-Text | Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
![Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01868-6/MediaObjects/41416_2022_1868_Fig1_HTML.png)